Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
Location: New Haven CT, Trumbull CT, Fairfax VA, Nashville TN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07519655
Phase1, Recruiting
Distance-Based Exercise to Preserve Function and Prevent Disability
for
Localized Malignant Solid Neoplasm, Anal Cancer,
Location: Boston MA, Indiana PA, Kernersville NC,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07059884
Recruiting
Volume Outcome Relationships and Effects
for
Esophageal Cancer
Location: Richardson TX
Sponsor: Methodist Health System
Sex: All
Age: 18+
Code: NCT06343597
Recruiting
Interested in new esophageal cancer trials?
Get alerts for new trials in your area by subscribing now
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2